CYCLOPHOSPHAN

Cyclophosphamide

Composition: each vial contains:

active substance:cyclophosphamide – 200 mg.

Therapeutic indications

Small cell carcinoma of the lung, ovarian carcinoma, breast cancer, cancer of the neck and of the body of the uterus, urinary bladder cancer, prostate cancer, neuroblastoma, retinoblastoma, lymphogranulomatosis, lymphosarcoma, non-Hodgkin lymphoma, reticulosarcoma, osteogenous sarcoma, multiple myeloma, chronic lympholeukemia and myeloleukemia and monoblastic leukemia, Wilms’ tumor, Ewing’s tumor, granulosarcoid, pulpy testis; autoimmune disease: rheumatoid arthritis, psoriatic arthritis, systemic disorders of the connective tissue, autoimmune hemolytic anemia, nephritic syndrome, suppression of the host-against-transplant reaction.

	АТС code
	L01AA01
	Pharmaceutical form
	powder for preparing solution for injection
	Storage conditions
	Store in protected from moisture and light place, at the temperature below 25ºС.